Bromhexine hydrochloride

Suppliers

Names

[ CAS No. ]:
611-75-6

[ Name ]:
Bromhexine hydrochloride

[Synonym ]:
Brombenzonium
Bisolvon
Auxit
BROMHEXINE HYDROCHLORIDE
N-Cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)ammonium chloride
2,4-Dibromo-6-{[cyclohexyl(methyl)amino]methyl}aniline hydrochloride (1:1)
MFCD00056626
3,5-Dibromo-Na-cyclohexyl-Na-methyltoluene-a,2-diamine Hydrochloride
Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, hydrochloride (1:1)
Benzenemethanamine, 2-amino-3,5-dibromo-N-cyclohexyl-N-methyl-, monohydrochloride
Bromhexine chloride
Benzylamine, 2-amino-N-cyclohexyl-3,5-dibromo-N-methyl-, hydrochloride
EINECS 210-280-8
2-Amino-N-cyclohexyl-3,5-dibromo-N-methylbenzylamine hydrochloride
Bromhexine (hydrochloride)

Chemical & Physical Properties

[ Boiling Point ]:
441.5ºC at 760 mmHg

[ Melting Point ]:
240-244 °C

[ Molecular Formula ]:
C14H21Br2ClN2

[ Molecular Weight ]:
412.591

[ Flash Point ]:
220.8ºC

[ Exact Mass ]:
409.975983

[ PSA ]:
29.26000

[ LogP ]:
5.94150

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XS9950000
CHEMICAL NAME :
Toluene-alpha,2-diamine, 3,5-dibromo-N(sup alpha)-cyclohexyl-N-(sup alpha)-methyl-, monohydrochloride
CAS REGISTRY NUMBER :
611-75-6
LAST UPDATED :
199609
DATA ITEMS CITED :
9
MOLECULAR FORMULA :
C14-H20-Br2-N2.Cl-H
MOLECULAR WEIGHT :
412.64
WISWESSER LINE NOTATION :
L6TJ AXZ1&R BZ CE EE &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
6 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - tremor Behavioral - ataxia
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 3,259,1969
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1680 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Behavioral - tremor Behavioral - ataxia
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 3,259,1969
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>14 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
YKYUA6 Yakkyoku. Pharmacy. (Nanzando, 4-1-11, Yushima, Bunkyo-ku, Tokyo, Japan) V.1- 1950- Volume(issue)/page/year: 35(1),-,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ZPPLBF Zentralblatt fuer Pharmazie, Pharmakotherapie und Laboratoriums-diagnostik. (VEB Verlag Volk und Gesundheit, Neue Gruenstr. 18, 102 Berlin, Ger. Dem. Rep.) V.109- 1970- Volume(issue)/page/year: 109,385,1970
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2210 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 3,259,1969
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>14 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,737,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
44 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 3,259,1969
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
10 gm/kg
TOXIC EFFECTS :
Cardiac - other changes Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 163,284,1966 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2400 mg/kg/8D-I
TOXIC EFFECTS :
Related to Chronic Data - death
REFERENCE :
FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 34,243,1979

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
R20/21/22

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
2

[ RTECS ]:
XS9950000

[ HS Code ]:
2921590090

Precursor & DownStream

Precursor

DownStream

  • 2-Amino-3,5-dibromobenzaldehyde
  • 6,8-dibromo-3-cyclohexylquinazolin-4-one
  • N-[2,4-dibromo-6-[(cyclohexylmethylamino)methyl]phenyl]acetamide
  • Cyclohexanamine,N-methyl-N-nitroso-

Customs

[ HS Code ]: 2921590090

[ Summary ]:
2921590090. other aromatic polyamines and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Investigation of internal structure of fine granules by microtomography using synchrotron X-ray radiation.

Int. J. Pharm. 445(1-2) , 93-8, (2013)

Computed tomography (CT) using synchrotron X-ray radiation was evaluated as a non-destructive structural analysis method for fine granules. Two kinds of granules have been investigated: a bromhexine h...

Structural changes of polymer-coated microgranules and excipients on tableting investigated by microtomography using synchrotron X-ray radiation.

Int. J. Pharm. 481(1-2) , 132-9, (2015)

Multiple-unit tablets consisting of polymer-coated microgranules and excipients have a number of advantageous pharmaceutical properties. Polymer-coated microgranules are known to often lose their func...

Predicting prognosis in idiopathic pulmonary fibrosis.

Sarcoidosis Vasc. Diffuse Lung Dis. 27(2) , 85-95, (2010)

Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. In 2002, the ATS/ERS published new criteria that significantly changed the definit...


More Articles


Related Compounds

  • Bromhexine hydrochloride Impurity TB
  • Tyrocidine, hydrochloride
  • Triprolidine hydrochloride
  • Minoxidil hydrochloride
  • Ebaresdax hydrochloride
  • dodecylamine hydrochloride
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 4-fluoro-3-[(methylsulfanyl)methyl]benzoate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 2-(2H-indazol-2-yl)acetate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 4-chloro-2-(ethylsulfanyl)benzoate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 4-(trifluoromethyl)pyridine-2-carboxylate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 3,3-dimethylcyclohexane-1-carboxylate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 2-[(3,3,3-trifluoropropyl)sulfanyl]acetate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 3-(5-methyl-1,2-oxazol-3-yl)propanoate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 2-methyl-3-[(trifluoromethyl)sulfanyl]propanoate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 2-(pyridin-2-yloxy)acetate
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 3,5-dimethylcyclohexane-1-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.